Who invested in Cardea Bio, Inc.?
Cardea Bio, Inc.'s investors include 3E Bioventures. 3E Bioventures led its latest round.
United States · Series A startup
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$6.5Mraised across 1 round since 2021, from 1 source
Reported by Firms' own news pagesSEC filing: $1.7M sold, first sale Sept 2020
Cardea Bio, Inc.'s investors include 3E Bioventures. 3E Bioventures led its latest round.
Cardea Bio, Inc. has raised $6.5M across 1 round since 2021.
Cardea Bio, Inc.'s most recent round was a Series A of $6.5M in Jan 2021, led by 3E Bioventures.
Its most recent round, $6.5M in Jan 2021, is also its largest on record.
Cardea Bio, Inc.'s first round on record, in Jan 2021, was backed by 3E Bioventures.
Cardea Bio, Inc.'s latest named round is a Series A, in Jan 2021.
Cardea Bio, Inc. is based in the United States.
3E Bioventures led the Series A in 2021.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.